Search clinical trials for: breast cancer progression
Total 89951 results
-
Hospices Civils de LyonNot yet recruiting
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
Novartis PharmaceuticalsNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingAdvanced Breast Cancer | Objective Response Rate | Trastuzumab EmtansineChina
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Mansoura UniversityRecruitingBreast Cancer Stage IVEgypt
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Taizhou EOC Pharma Co., Ltd.Not yet recruiting
-
Carey Anders, M.D.Seagen Inc.RecruitingAdvanced Breast Cancer | Brain Metastases | Human Epidermal Growth Factor 2 Positive Carcinoma of BreastUnited States
-
The Netherlands Cancer InstituteMaarten van de Weijden FoundationRecruitingOligoprogressive | Metastatic Cancer | Breast Cancer InvasiveNetherlands
-
Stanford UniversityPatient-Centered Outcomes Research InstituteRecruitingComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerCancer | End of LifeUnited States
-
Fudan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
National Cancer Institute (NCI)RecruitingGynecologic Cancer | Colorectal Neoplasms | Colorectal Cancer | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Peritoneal Carcinomatosis | Appendiceal Neoplasms | Appendiceal Cancer | Gynecologic NeoplasmsUnited States
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
UNICANCERSeagen Inc.; ARCAGY/ GINECO GROUPRecruitingMetastatic Breast Cancer With a Isolated Brain ProgressionFrance
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
Novartis PharmaceuticalsRecruitingHormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationSpain, Italy, Austria
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Sohag UniversityRecruiting
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingVitamin D Deficiency | Triple Negative Breast Cancer | Invasive Breast CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingProstate CarcinomaUnited States, Puerto Rico, Guam
-
University Hospital Schleswig-HolsteinRecruitingMetastatic Breast CancerGermany
-
Taproot HealthRecruitingMelanoma | Sarcoma | Kidney Cancer | Adenocarcinoma | Renal Cell Carcinoma | Cervical Cancer | Acute Myeloid Leukemia | Stomach Cancer | Breast Cancer | Head and Neck Neoplasms | Nasopharyngeal Carcinoma | Glioblastoma | Astrocytoma | Multiple Myeloma | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer and other conditionsUnited States
-
Institut Cancerologie de l'OuestEli Lilly and Company; Novartis; AstraZeneca; European Regional Development FundRecruitingBreast CancerFrance
-
VM Oncology, LLCRecruitingSarcoma | Cervical Cancer | Breast Cancer | Adenoid Cystic Carcinoma | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Thymic Carcinoma | Lung Cancer | Mesothelioma | Bladder Cancer | Head and Neck Carcinoma | Any Solid Tumors Progressed After a Prior ImmunotherapyUnited States, Puerto Rico
-
Centre Jean PerrinConseil National des Etablissements ThermauxActive, not recruitingQuality of Life | Remission | Non-Metastatic Breast CarcinomaFrance
-
PrecirixTerminatedAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
M.D. Anderson Cancer CenterActive, not recruiting
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
SOLTI Breast Cancer Research GroupMerck Sharp & Dohme LLCActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer... and other conditionsUnited States
-
AtlasMedx, IncorporatedActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Homologous Recombination Deficiency | Advanced Malignant NeoplasmUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingKidney CancerUnited States, Puerto Rico
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States, Canada
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
amy tierstenNovartisActive, not recruiting
-
Reata, a wholly owned subsidiary of BiogenTerminatedBrain MetastasesUnited States
-
Novartis PharmaceuticalsCompleted
-
Clinical Hospital Center RijekaCompletedSentinel Lymph Node Biopsy | Progression, Disease | Locoregional Neoplasm Recurrence
-
Steven J Isakoff, MD, PhDDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AbbottActive, not recruitingBreast Cancer | Metastatic Breast Cancer | BRCA1 Gene Mutation | brca2 Gene MutationUnited States
-
Melissa K AccordinoNovartis PharmaceuticalsActive, not recruitingMetastatic Breast Cancer | Breast CarcinomaUnited States
-
BeiGeneMyriad Genetics, Inc.CompletedLocally Advanced or Metastatic Solid TumorsSpain, Australia, United States, United Kingdom
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
The Netherlands Cancer InstituteRoche Pharma AGTerminatedBreast CancerNetherlands
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States